ESTRO 2024 - Abstract Book

S1168

Clinical - Haematology

ESTRO 2024

Lee YS, Heo W, Nam J, et al. The combination of ionizing radiation and proteasomal inhibition by bortezomib enhances the expression of NKG2D ligands in multiple myeloma cells. J Radiat Res. 2018; 59(3): 245 – 252, doi: 10.1093/jrr/rry005, indexed in Pubmed: 29518205. 15. Pak O, Zaitsev S, Shevchenko V, et al. Effectiveness of bortezomib and temozolomide for eradication of recurrent human glioblastoma cells, resistant to radiation. Prog Brain Res. 2021; 266: 195 – 209, doi: 10.1016/bs.pbr.2021.06.010, indexed in Pubmed: 34689859. 16. Landgren O, Kazandjian D. Diagnosed with myeloma before age 40. Blood. 2021; 138(25): 2601 – 2602, doi: 10.1182/blood.2021013539, indexed in Pubmed: 34940818. 17. Tsang RW, Campbell BA, Goda JS, et al. Radiation Therapy for Solitary Plasmacytoma and Multiple Myeloma: Guidelines From the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2018; 101(4): 794 – 808, doi: 10.1016/j.ijrobp.2018.05.009, indexed in Pubmed: 29976492. 18. Furuya Y. Early neutropenia on day 8 treated with adjuvant Docetaxel-based chemotherapy in early breast cancer patients: Putative mechanisms within the neutrophil pool system. PLoS One. 2019; 14(4): e0215576, doi: 10.1371/journal.pone.0215576, indexed in Pubmed: 30998754. 19. Shuja M, Elghazaly AA, Iqbal A, et al. Efficacy of 8 Gy Single Fraction Palliative Radiation Therapy in Painful Bone Metastases: A Single Institution Experience. Cureus. 2018; 10(1): e2036, doi: 10.7759/cureus.2036, indexed in Pubmed: 29541557. 20. Rades D, Hoskin PJ, Stalpers LJA, et al. Short-course radiotherapy is not optimal for spinal cord compression due to myeloma. Int J Radiat Oncol Biol Phys. 2006; 64(5): 1452 – 1457, doi: 10.1016/j.ijrobp.2005.10.018, indexed in Pubmed: 16413695. 21. Rudzianskiene M, Inciura A, Gerbutavicius R, et al. Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma : A prospective randomised study. Strahlenther Onkol. 2017; 193(9): 742 – 749, doi: 10.1007/s00066-017-1154-5, indexed in Pubmed: 28573476. 22. Elhammali A, Amini B, Ludmir EB, et al. New paradigm for radiation in multiple myeloma: lower yet effective dose to avoid radiation toxicity. Haematologica. 2020; 105(7): e355 – e357, doi: 10.3324/haematol.2019.235804, indexed in Pubmed: 31919088. 23. Suh YG, Suh CO, Kim JS, et al. Radiotherapy for solitary plasmacytoma of bone and soft tissue: outcomes and prognostic factors. Ann Hematol. 2012; 91(11): 1785 – 1793, doi: 10.1007/s00277-012-1510-6, indexed in Pubmed: 22752147. 24. Raje N, Anaissie E, Kumar S, et al. Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group. Lancet Haematol. 2022; 9(2): e143 – e161, doi: 10.1016/s2352-3026(21)00283-0.

2322

Digital Poster

Radiotherapy for gastric lymphoma. A proposal for improving treatment delivery and reproducibility